查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654443

病毒惰性市場規模、佔有率、趨勢分析報告：按產品/服務、應用、最終用途、地區和細分市場進行預測，2025 年至 2030 年

Viral Inactivation Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents), By Application (Vaccines & Therapeutics), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

病毒惰性市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球病毒惰性市場規模預計到2030年將達到13.716億美元，2025-2030年期間的複合年成長率為11.58%。

製藥和生物製藥公司數量的增加、FDA核准的藥物數量的增加、生命科學產業的成長以及政府對新療法和藥物開發的資助增加是促進成長的一些主要因素。

隨著公司數量、新藥上市數量和新藥發現數量的穩定增加，製藥和生物製藥行業正在經歷顯著的成長。隨著全球疾病數量的增加，全球對新藥物和改良治療方法的需求也日益成長。主要企業增加對研發的投入，加上尋找治療疾病的新治療方法的需求，促進並加速了製藥和生物製藥公司的成長。

公司開發新藥來增強健康效益。世界各地人們的生活方式改變，導致久坐不動的生活方式，這是需要藥物和治療方法治療的慢性病增加的主要原因。根據 FDA 統計，2014 年核准了核准種新藥，隔年核准了 45 種新藥。這也有助於成長。

近年來，巨額資金湧入製藥和生技產業。在私人公司為新藥和新治療方法的開發做出重大貢獻的同時，政府對新治療方法研發的支出也在增加。資金的增加也導致近年來 FDA核准數量的增加。所有這些因素都促進了病毒惰性市場的巨大成長。

病毒去活化市場報告重點

  • 套件和試劑產品部門佔據市場主導地位，2024 年的收益佔有率最大，為 57.37%。
  • 根據應用，由於對基因治療和幹細胞研究等研發應用的投資不斷增加，疫苗和治療部門將在 2024 年佔據最大的收益佔有率，為 34.41%。
  • 2024 年，製藥和生物技術公司板塊以 38.51% 的最大收益佔有率引領市場。
  • 北美佔據了最大的佔有率，因為那裡擁有主要企業和先進的基礎設施，以及抑制慢性病發病率的醫療改革。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章病毒去活化變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章：病毒去活化市場 - 按產品/服務進行的估計和趨勢分析

  • 產品/服務細分儀表板
  • 全球病毒去活化市場產品與服務變化分析
  • 2018 年至 2030 年全球病毒去活化市場規模及趨勢分析（依產品及服務）
  • 套件和試劑
  • 系統和配件
  • 服務

第 5 章：病毒去活化市場：按應用的估計和趨勢分析

  • 應用程式細分儀表板
  • 全球病毒去活化市場應用變遷分析
  • 2018 年至 2030 年全球病毒去活化市場規模與趨勢分析（按應用）
  • 疫苗和治療
  • 幹細胞產品
  • 血液和血液製品
  • 紙巾/紙巾產品
  • 細胞和基因治療

第 6 章：病毒去活化市場 - 最終用途、估計與趨勢分析

  • 最終用途細分儀表板
  • 全球病毒去活化市場最終用途變化分析
  • 2018 年至 2030 年全球病毒去活化市場規模及趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • CRO
  • 學術研究所
  • 其他

第 7 章：病毒去活化市場：區域、估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030 年市場規模、預測及趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 參與企業
  • 2024 年企業市場分析
  • 參與企業概況
    • Charles River Laboratories, Inc.
    • Clean Cells
    • Cytiva（Danaher Corporation）
    • Merck KGaA
    • Mettler Toledo
    • Parker Hannifin Corp
    • Rad Source Technologies Inc
    • Sartorius AG
    • Texcell SA
    • Vironova AB
Product Code: GVR-1-68038-998-2

Viral Inactivation Market Growth & Trends:

The global viral inactivation market size is estimated to reach USD 1,371.6 million by 2030, registering a CAGR of 11.58% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rise in the number of pharmaceutical and biopharmaceutical companies, increase in FDA drug approvals, growth of the life sciences industry, increase in government funding for novel therapies, and drug development are some of the major factors contributing to the growth.

Immense growth has been witnessed in the pharmaceutical and biopharmaceutical industry with a steady rise in the number of companies, drug launches, and new drug discoveries. With an increase in the number of diseases worldwide, the need for new & improved drugs and therapies has been witnessed on a global front. Increase in investment by top players in research and development coupled with the need to find new therapies for the treatment of diseases has contributed to immense growth of pharmaceutical and biopharmaceutical companies, thereby accelerating growth.

Newer drugs are being developed by companies to offer incremental health benefits. Changing lifestyle of people across the globe and adoption of sedentary living habits are primary reasons responsible for the increase in the number of chronic diseases that require drugs and therapies for treatment. According to the FDA, in the year 2014, 41 novel drugs were approved and 45 in the consequent year. This has also been contributing to growth.

Immense funding has been witnessed in the pharmaceutical and biotechnology industries in the recent years. It has been observed that private players are the major contributors for the development of new drugs and therapies, however, there has been increasing government spending on the research and development of new therapies. Increase in funding has also resulted in growth in number of FDA approvals over the recent years. All these factors have been contributing to the immense growth of the viral inactivation market.

Viral Inactivation Market Report Highlights:

  • The kits & reagents product segment led the market with the largest revenue share of 57.37% in 2024, attributed to the rise in biopharmaceutical and biotechnological companies worldwide.
  • By application, the vaccines and therapeutics segment held the largest revenue share of 34.41% in 2024, attributed to the rising investments in R&D applications such as gene therapy and stem cell research.
  • In 2024, the pharmaceutical and biotechnology companies segment led the market with the largest revenue share of 38.51%, attributed to the growth of pharmaceutical and biopharmaceutical companies.
  • North America accounted for the largest share owing to presence of dominant players and availability of sophisticated infrastructure along with healthcare reforms to curb the incidence of chronic diseases.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Viral Inactivation Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand for Biopharmaceuticals
      • 3.2.1.2. Technological Advancements in Viral Inactivation
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Viral Inactivation Techniques
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Viral Inactivation Market: Product & Services Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global Viral Inactivation Market Product & Service Movement Analysis
  • 4.3. Global Viral Inactivation Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Kits & Reagents
    • 4.4.1. Kits & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Systems & Accessories
    • 4.5.1. Systems & Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Viral Inactivation Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Viral Inactivation Market Application Movement Analysis
  • 5.3. Global Viral Inactivation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Vaccines & Therapeutics
    • 5.4.1. Vaccines & Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Stem Cell Products
    • 5.5.1. Stem Cell Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Blood & Blood Products
    • 5.6.1. Blood & Blood Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Tissue/ Tissue Products
    • 5.7.1. Tissue/ Tissue Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Cellular and Gene Therapy
    • 5.8.1. Cellular and Gene Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Viral Inactivation Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global Viral Inactivation Market End Use Movement Analysis
  • 6.3. Global Viral Inactivation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnological Companies
    • 6.4.1. Pharmaceutical & Biotechnological Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. CROs
    • 6.5.1. CROs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Academic and Research Institutes
    • 6.6.1. Academic and Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Viral Inactivation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. North America Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. UK Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. South Korea Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Viral Inactivation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant's Overview
    • 8.3.1. Charles River Laboratories, Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product/Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Clean Cells
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product/Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Cytiva (Danaher Corporation)
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product/Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Merck KGaA
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product/Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Mettler Toledo
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product/Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Parker Hannifin Corp
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product/Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Rad Source Technologies Inc
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product/Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Sartorius AG
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product/Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Texcell SA
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product/Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Vironova AB
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product/Service Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 6 Global viral inactivation market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 North America viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 11 U.S. viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 12 U.S. viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Canada viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 15 Canada viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Mexico viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 18 Mexico viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Europe viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 22 Europe viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 25 UK viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Germany viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 28 Germany viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 30 France viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 31 France viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 32 France viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Italy viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 Italy viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 37 Spain viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Denmark viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 40 Denmark viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 41 Denmark viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Sweden viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 43 Sweden viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 44 Sweden viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Norway viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Norway viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 47 Norway viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 53 Japan viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 54 Japan viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 55 China viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 56 China viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 57 China viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 58 India viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 59 India viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 60 India viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Australia viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 62 Australia viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Thailand viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 65 Thailand viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 66 Thailand viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 67 South Korea viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 68 South Korea viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 69 South Korea viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Latin America viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 72 Latin America viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 73 Latin America viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 74 Brazil viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 75 Brazil viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 76 Brazil viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Argentina viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 78 Argentina viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa viral inactivation market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 85 South Africa viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 91 UAE viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait viral inactivation market, by product & service, 2018 - 2030 (USD Million)
  • Table 94 Kuwait viral inactivation market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait viral inactivation market, by end use, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new product & services
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Viral inactivation market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Viral inactivation market driver analysis
  • Fig. 12 Viral inactivation market restraint analysis
  • Fig. 13 Viral inactivation market: Porter's analysis
  • Fig. 14 Viral inactivation market: PESTEL analysis
  • Fig. 15 Viral inactivation market: Product & service outlook and key takeaways
  • Fig. 16 Viral inactivation market: Product & service market share analysis, 2024 - 2030
  • Fig. 17 Global viral inactivation market for kits and reagents, 2018 - 2030 (USD Million)
  • Fig. 18 Global viral inactivation market for systems & accessories, 2018 - 2030 (USD Million)
  • Fig. 19 Global viral inactivation market for services, 2018 - 2030 (USD Million)
  • Fig. 20 Viral inactivation market: Application outlook and key takeaways
  • Fig. 21 Viral inactivation market: Application market share analysis, 2024 - 2030
  • Fig. 22 Global viral inactivation market for vaccines and therapeutics, 2018 - 2030 (USD Million)
  • Fig. 23 Global viral inactivation market for stem cell products, 2018 - 2030 (USD Million)
  • Fig. 24 Global viral inactivation market for blood and blood products, 2018 - 2030 (USD Million)
  • Fig. 25 Global viral inactivation market for tissue/tissue products, 2018 - 2030 (USD Million)
  • Fig. 26 Global viral inactivation market for cellular and gene therapy, 2018 - 2030 (USD Million)
  • Fig. 27 Viral inactivation market: End use outlook and key takeaways
  • Fig. 28 Viral inactivation market: End use market share analysis, 2024 - 2030
  • Fig. 29 Global viral inactivation market for pharmaceutical and biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 30 Global viral inactivation market for CROs, 2018 - 2030 (USD Million)
  • Fig. 31 Global viral inactivation market for academic & research institutes, 2018 - 2030 (USD Million)
  • Fig. 32 Global viral inactivation market for others, 2018 - 2030 (USD Million)
  • Fig. 33 Regional marketplace: Key takeaways
  • Fig. 34 North America viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Canada viral inactivation, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Europe viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 UK viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Germany viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 France viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Italy viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Spain viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Norway viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Asia-Pacific viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Japan viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 China viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 India viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Australia viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 MEA viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 UAE viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait viral inactivation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Key company categorization
  • Fig. 63 Company market positioning
  • Fig. 64 Market participant categorization
  • Fig. 65 Strategy framework